pentobarbital will lower the extent or influence of aripiprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will decrease the extent or impact of diltiazem by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
Watch Carefully (one)pentobarbital will decrease the level or influence of benzhydrocodone/acetaminophen by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Caution when discontinuing CYP3A4 inducers which might be coadministered with benzhydrocodone (prodrug of hydrocodone); plasma concentrations of hydrocodone may boost and may lead to potentially fatal respiratory melancholy.
fentanyl transmucosal and pentobarbital the two boost sedation. Keep away from or Use Alternate Drug. Limit use to individuals for whom substitute therapy choices are insufficient
pentobarbital will decrease the extent or outcome of levoketoconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unfamiliar.
Minor (one)pentobarbital will reduce the level or influence of paclitaxel protein sure by influencing hepatic/intestinal enzyme more info CYP3A4 metabolism. Small/Significance Unfamiliar.
pentobarbital will minimize the extent or effect of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not encouraged; strong cytochrome P450 enzyme inducers decrease systemic exposure to roflumilast and may reduce the therapeutic usefulness
pentobarbital will minimize the extent or impact of donepezil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.
pentobarbital will lessen the extent or impact of colchicine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lower the level or outcome of estradiol vaginal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will reduce the level or result of vincristine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unfamiliar.
Use an alternative means of contraception or even a backup method when enzyme inducers are utilised with combined hormonal contraceptives (CHCs), and continue on backup contraception for 28 days immediately after discontinuing enzyme inducer to ensure contraceptive dependability.
Too rapid administration may induce respiratory melancholy, laryngospasm, apnea, or vasodilation with slide in hypertension
pentobarbital will reduce the extent or effect of glecaprevir/pibrentasvir by impacting hepatic/intestinal enzyme CYP3A4 metabolism.